Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Option Care Health (OPCH)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL – Research Report) and Option Care Health (OPCH – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Charles River Labs (CRL)
William Blair analyst Max Smock reiterated a Buy rating on Charles River Labs today. The company’s shares closed last Monday at $218.82.
According to TipRanks.com, Smock is a 3-star analyst with an average return of
Charles River Labs has an analyst consensus of Moderate Buy, with a price target consensus of $202.10, which is a -8.6% downside from current levels. In a report issued on January 2, Citi also maintained a Buy rating on the stock.
See the top stocks recommended by analysts >>
Option Care Health (OPCH)
William Blair analyst Matt Larew maintained a Buy rating on Option Care Health today. The company’s shares closed last Monday at $32.06.
According to TipRanks.com, Larew is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Option Care Health with a $36.22 average price target, which is a 14.0% upside from current levels. In a report released today, TipRanks – DeepSeek also reiterated a Buy rating on the stock with a $35.00 price target.
